According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.

Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market.

Some of the key players in this market include are Mylan, Inc., Dr. Reddy’s Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.

Products Covered:

  • Peptides
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Monoclonal Antibodies
  • Granulocyte Colony Stimulating Factor (G-CSF)
  • Insulin
  • Other Products



Technology Covered:

  • Bioassay
  • Mass Spectrometry
  • Nuclear magnetic resonance (NMR) technology
  • Recombinant DNA Technology (rDNA technology)
  • Western Blotting
  • Electrophoresis
  • Chromatography
  • Monoclonal Antibodies (MAb) Technology



Application Covered:

  • Growth Hormone Deficiency
  • Chronic and Autoimmune Diseases
  • Blood Disorders
  • Oncology Diseases
  • Other Applications



Service Covered:

  • Clinical Trials
  • Contract Research and Manufacturing Services



Regions Covered:

  • North America
  • ·US
  • ·Canada
  • ·Mexico
  • Europe
  • ·Germany
  • ·France
  • ·Italy
  • ·UK
  • ·Spain
  • ·Rest of Europe
  • Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Australia
  • ·New Zealand
  • ·Rest of Asia Pacific
  • Rest of the World
  • ·Middle East
  • ·Brazil
  • ·Argentina
  • ·South Africa
  • ·Egypt



What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements